Sustained release lipidic pellet matrix: NestleRecent Research Landscape
Liquid cannabinoid instability and poor bioavailability lead to inconsistent dosing and rapid degradation. Engineering a solid-state oil composition stabilizes the active species for controlled central nervous system delivery.
What technical problems is Nestle addressing in Sustained release lipidic pellet matrix?
Poor cannabinoid oral bioavailability
(1)evidences
Lipophilic cannabinoid oils suffer from extensive first-pass metabolism and erratic absorption in the gastrointestinal tract. Overcoming this limitation ensures consistent therapeutic concentrations for central nervous system treatment.